IGC

IGC Pharma Inc

• TipRanks·07/29 12:40

  IGC Pharma evaluates potential civil remedies following federal jury verdict

• TipRanks·07/07 13:26

  IGC Pharma CEO, principal financial officer purchase over $1.15M of stock

• Seeking Alpha·07/07 13:23

  IGC Pharma CEO, finance chief buy $1.15M of common stock

• TipRanks·07/06 20:41

  IGC Pharma Executives Convert Debt Into Equity Shares

• TipRanks·06/23 16:59

  IGC Pharma announced beta version of Agentic Harmonization Assistant

• TipRanks·06/11 12:43

  IGC Pharma reaches 146-patient enrollment target for Phase 2 Calma trial

• TipRanks·06/08 21:16

  IGC Pharma Extends and Amends $12 Million Loan Facility

• Dow Jones·06/08 09:31

  IGC Pharma Price Target Raised to $5.50/Share From $5.25 by Ascendiant Capital

• Dow Jones·06/08 09:31

  IGC Pharma Is Maintained at Buy by Ascendiant Capital

• TipRanks·06/02 15:20

  IGC Pharma adds Mount Sinai clinical site as CALMA trial advances

• Seeking Alpha·05/19 21:32

  IGC Pharma GAAP EPS of -$0.02 in-line, revenue of $0.32M beats by $0.09M

• TipRanks·05/15 13:00

  IGC Pharma to present new Tau-PET biomarker research at Global Tau conference

• TipRanks·04/24 09:00

  Analysts Are Bullish on Top Healthcare Stocks: IGC Pharma (IGC), 60 Degrees Pharmaceuticals, Inc. (SXTP)

• TipRanks·04/23 17:06

  Roth views partial cannabis re-scheduling order as ‘extremely favorable’

• TipRanks·04/23 14:26

  Trump Trade: Trump officials reclassify state-licensed medical marijuana